This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (19)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Alert me on articles by topic

No

William M. Landau, MD
From the Department of Neurology, Washington University School of Medicine, St Louis, Mo.

Arch Neurol. 1999;56:1521-1524.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

EASY, NO! But the counterquery is, Why bother? Answer: In the interest of our patients, we should be less incompetent concerning the pathogenesis and treatment of stroke. (Furthermore, NO also means nitric oxide; vide infra.) What's the rationale for our reasoning?

First let's parse and define the terms of the question. "Is," an intransitive verb, is the present tense of being now. "Cholesterol" is

the most abundant steroid in animal tissues, especially in bile and gall stones, and present in food, especially that rich in animal fats; circulates in the plasma complexed to proteins of various densities and [Stedman describes first structure and place, and now what must be presumed to be its major function] plays an important role in the pathogenesis of atheroma formation in arteries.¹

RELATED ARTICLES

Is Cholesterol a Risk Factor for Stroke?: Yes
Andrew M. Demchuk, David C. Hess, Lawrence M. Brass, and Frank M. Yatsu
Arch Neurol. 1999;56(12):1518-1520.
EXTRACT | FULL TEXT  

Cholesterol as a Risk Factor for Stroke
Vladimir Hachinski
Arch Neurol. 1999;56(12):1524.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Higher Total Serum Cholesterol Levels Are Associated With Less Severe Strokes and Lower All-Cause Mortality: Ten-Year Follow-Up of Ischemic Strokes in the Copenhagen Stroke Study
Olsen et al.
Stroke 2007;38:2646-2651.
ABSTRACT | FULL TEXT  

Cerebral Vascular Dysfunction During Hypercholesterolemia
Kitayama et al.
Stroke 2007;38:2136-2141.
ABSTRACT | FULL TEXT  

Editorial Comment-- Time to Burn the TOAST
Landau and Nassief
Stroke 2005;36:902-904.
FULL TEXT  

Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men
Engstrom et al.
Circulation 2002;105:2632-2637.
ABSTRACT | FULL TEXT  

Low- and High-Density Lipoprotein Cholesterol and Ischemic Cerebrovascular Disease: The Bezafibrate Infarction Prevention Registry
Koren-Morag et al.
Arch Intern Med 2002;162:993-999.
ABSTRACT | FULL TEXT  

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT | FULL TEXT  

Polymorphism of the Lipoprotein Lipase Gene and Risk of Atherothrombotic Cerebral Infarction in the Japanese
Shimo-Nakanishi et al.
Stroke 2001;32:1481-1486.
ABSTRACT | FULL TEXT